Cite
HARVARD Citation
Schweizer, M. et al. (2019). A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer. Stem cells translational medicine. pp. 441-449. [Online].